FDA Clearance Tracker · P240003-S001
Minima Stent System
Last checked: Nov 20, 2026Latest source record: Nov 8, 2024 (this decision)Source: openFDAMethods & limitations
Decided
Nov 8, 2024
Approved
Time to decision
46 days
Received Sep 23, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P240003-S001
- Device name
- Minima Stent System
- Applicant
- Renata Medical, Inc.
- Applicant location
- Newport Beach, CA
- Received
- Sep 23, 2024
- Decided
- Nov 8, 2024
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Postapproval Study Protocol
- Original approval
- P240003
Device type
- Device type
- Aortic stent (PNF)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
Approval for the revised protocol for the post-approval study (PAS) referenced above. The PAS protocol has been submitted to comply with the conditions of approval outlined in our approval order for P240003.
Source documents
Other decisions for Renata Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Minima Stent System and Minima Pro Stent SystemBreakthroughPMA
P240003 · Decided Aug 28, 2024 · 180 days after receipt
Device type: Aortic stent (PNF) · Cardiology
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.